Adjuvant Chemotherapy for Patients with Breast Cancer Based on Clinical and Evolving Oncotype DX Criteria

Faculty Medicine Year: 2020
Type of Publication: ZU Hosted Pages:
Authors:
Journal: Breast Care Karger Volume:
Keywords : Adjuvant Chemotherapy , Patients with Breast Cancer    
Abstract:
-Oncotype DX assay recurrence score (ODX-RS) cut-off values have recently changed after the publication of the TAILOR-X trial results. We aim to explore decisions for adjuvant chemotherapy (ACT) based on physicians’ clinical assessment and the evolving ODX-RS. -Overtreatment and discrepancies in the management of patients with ER+/Her2–/LN– early BC can be minimized by the implementation of ODX genomic assay. Some differences in ACT recommendations exist between ODX-RS-1 and ODX-RS-2.
    
     
 
       

Author Related Publications

    Department Related Publications

    • Amarallah Abdelmoneim Mohamed Sayed, "The pattern of infection and antibiotics use in terminal cancer patients", www.nci.cu.adu.eg www.sciencedirect.com, 2014 More
    • Tarek Ali Mohamed Elgohary, "The Impact of miRNA-155 Expression on Treatment Outcome in Adult Acute Myeloid Leukemia Patients. تأثير وجود (miRNA-155) على نتائج العلاج في مرضى سرطان الدم النقوي الحاد للبالغين", Journal of Cancer Therapy (2019) 10(3), 203-214, 2019 More
    • Rasha Mohamed Mostafa Hagag, "Impact of Prognostic Nutritional Index and Systemic Immune-Inflammation Index on the Clinical Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib", Zagazig University Medical Journal, 2022 More
    • Amarallah Abdelmoneim Mohamed Sayed, "Impact of cyclin D1 and DJ-1 on diagnosis, clinico-pathological features and outcome in prostate cancer and benign prostatic hyperplasia", Sciendo, 2019 More
    • Amarallah Abdelmoneim Mohamed Sayed, "Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: Correlation between Androgen Receptor Expression and Pathological Response", Asian Pac J Cancer Prev, 2020 More
    Tweet